Professional Summary

Professional Overview

Scott Rudge is a seasoned pharmaceutical executive with over 20 years of experience in product development, operations, and academic research. As the Founder of Syner-G BioPharma Group and Senior Vice President of Product Development at Margaux Biologics, he leverages his deep expertise in chemical engineering and biopharmaceutical manufacturing to drive innovative solutions and accelerate the development of life-changing therapies.

Experience Summary

Current Roles

Founder, Syner-G BioPharma Group (2023-Present)

• Established a boutique consulting firm focused on providing strategic advisory and technical expertise to biopharmaceutical companies

• Collaborates with clients to optimize product development processes, enhance manufacturing capabilities, and navigate complex regulatory landscapes

Senior Vice President, Product Development, Margaux Biologics (2011-Present)

• Oversees all aspects of product development, including formulation, process design, and scale-up activities

• Leads cross-functional teams to advance novel biologics and biosimilars through clinical trials and commercialization

• Drives the implementation of cutting-edge technologies and best practices to improve production efficiency and product quality

Career Progression

Chief Operating Officer, RMC Pharmaceutical Solutions (2003-2023)

• Spearheaded the transformation of the organization's operational capabilities, resulting in increased productivity and cost savings

• Directed the successful implementation of several complex technology and process improvement initiatives

Senior Vice President, Product Development, Bradmer Pharma (2008-2009)

• Contributed to the development and regulatory approval of a novel small-molecule therapeutic for the treatment of rare diseases

Academic Background

• Ph.D. in Chemical Engineering, University of Colorado (1998)

• Adjunct Professor of Chemical Engineering, University of Colorado (1998-Present)

Areas of Expertise

• Biopharmaceutical product development and manufacturing

• Process optimization and scale-up

• Regulatory compliance and strategy

• Cross-functional team leadership and collaboration

• Technical and operational innovation

Professional Impact

• Developed and implemented advanced manufacturing processes that resulted in significant improvements in product yield and quality

• Served as a technical advisor for numerous biopharmaceutical companies, providing strategic guidance on complex project challenges

• Authored over 25 peer-reviewed publications and presented at various industry conferences, contributing to the advancement of the field

Conclusion

With his extensive experience, proven track record of success, and deep technical expertise, Scott Rudge is poised to continue driving innovation and value creation in the biopharmaceutical industry. As the Founder of Syner-G BioPharma Group and a key leader at Margaux Biologics, he remains committed to leveraging his expertise to accelerate the development and commercialization of transformative therapies that improve patient outcomes.